The immunosuppressive effects of GBM can be attributed to the elevated levels of TGF-β, since it promotes the stimulation of the M2 phenotype in macrophages with release of the immunosuppressive cytokine IL-10. The gene discussed is TGFB1; the disease is glioblastoma.